Tuesday, May 23, 2006

Final conference schedule

Hello,
this is supposed to be the final schedule of the scientific sessions of the 4th LCA conference. Judging from the presentations' titles, not a word should be missed!
I'll update this blog as soon as I can after the conference, maybe in realtime from Cleveland, with allthe exciting news that will come out. We cannot expect a miracle to happen in a few months, however with so much going on and considering the pace of research nowadays, we have good reason to hope that many of us who have lost their sight or who have never seen because of LCA will gain some vision one day not too far ahead.

Fran


FINAL CONFERENCE SCHEDULE

Saturday, July 29th 2006

Introduction
8:30-8:40 am Welcome and Opening Remarks
Dr. Hilel Lewis

Session 1: LCA Characteristics: Phenotypes and Genotypes

8:40-9:00 Clinical Characterization of LCA
Dr. Irene Maumenee

9:00-9:20 LCA Clinical Characterization: Phenotype- Genotype Relationships
Dr. Jill Hopkins

9:20-9:40 Genetic Testing in LCA
Dr. Edwin Stone

9:40-9:50 Q&A Session
Drs. Maumenee, Hopkins and Stone

Session 2: LCA Genes
9:50-10:10 LCA Gene Update
Dr. Steven Daiger

10:10-10:30 The Role of TULP1 in LCA
Dr. Stephanie Hagstrom

10:30-11:00 Break

11:00-11:20 Finding New LCA Genes
Dr. Robert Koenekoop

11:20-11:30 Q&A Session
Drs.Daiger, Hagstrom and Koenekoop

Session 3:
11:30-11:50 "Photoreceptor Development and Disease"
Dr. Connie Cepko

11:50-12:10 Gene Therapy
Dr. Jean Bennett

12:10-12:30 Stem Cell and Transplantation
Dr. Vas Sadda

12:30-12:40 Q&A Session
Drs. Cepko, Bennett and Sadda

12:40-1:30 Lunch

Session 4: LCA Therapies 2
1:30-1:50 Retinal Electronic Prostheses
Dr. Mark Humayun

1:50-2:10 Pharmaceutical Therapy
Dr. Gerald Chader

2:10-2:30 Potential for Retinoid Treatment in LCA
Dr. Krzysztof Palczewski

2:30-2:40 Q&A Session
Drs.Humayun, Chader and Palczewski

2:40-3:00 Break

Session 5 Summary and Conclusions

3:00-3:30 The Commercial Pathway to LCA Treatments
Dr. Eugene de Juan

3:30-4:00 Towards Treatments and Cures for LCA
Dr. Elias Traboulsi

4:00:4:30 General Questions and Answer Session

0 comments: